vs
PTC THERAPEUTICS, INC.（PTCT）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
PTC THERAPEUTICS, INC.的季度营收约是REPUBLIC BANCORP INC的1.7倍（$164.7M vs $94.3M），REPUBLIC BANCORP INC净利率更高（24.2% vs -82.0%，领先106.2%），REPUBLIC BANCORP INC同比增速更快（5.3% vs -22.7%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $-36.6M），过去两年PTC THERAPEUTICS, INC.的营收复合增速更高（-11.5% vs -11.5%）
PTC Therapeutics是一家总部位于美国的制药企业，专注于开发口服小分子药物及基因疗法，通过靶向转录后调控机制调节基因表达，相关产品管线主要面向罕见病治疗领域，致力于满足相关疾病未被覆盖的临床治疗需求。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
PTCT vs RBCAA — 直观对比
营收规模更大
PTCT
是对方的1.7倍
$94.3M
营收增速更快
RBCAA
高出28.1%
-22.7%
净利率更高
RBCAA
高出106.2%
-82.0%
自由现金流更多
RBCAA
多$197.8M
$-36.6M
两年增速更快
PTCT
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $164.7M | $94.3M |
| 净利润 | $-135.0M | $22.8M |
| 毛利率 | — | — |
| 营业利润率 | -43.3% | 29.3% |
| 净利率 | -82.0% | 24.2% |
| 营收同比 | -22.7% | 5.3% |
| 净利润同比 | -104.8% | 20.0% |
| 每股收益（稀释后） | $-1.63 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PTCTRBCAA
| Q4 25 | $164.7M | $94.3M | ||
| Q3 25 | $211.0M | $93.5M | ||
| Q2 25 | $178.9M | $93.8M | ||
| Q1 25 | $1.2B | $135.8M | ||
| Q4 24 | $213.2M | $89.5M | ||
| Q3 24 | $196.8M | $88.1M | ||
| Q2 24 | $186.7M | $86.9M | ||
| Q1 24 | $210.1M | $120.3M |
净利润PTCTRBCAA
| Q4 25 | $-135.0M | $22.8M | ||
| Q3 25 | $15.9M | $29.7M | ||
| Q2 25 | $-64.8M | $31.5M | ||
| Q1 25 | $866.6M | $47.3M | ||
| Q4 24 | $-65.9M | $19.0M | ||
| Q3 24 | $-106.7M | $26.5M | ||
| Q2 24 | $-99.2M | $25.2M | ||
| Q1 24 | $-91.6M | $30.6M |
营业利润率PTCTRBCAA
| Q4 25 | -43.3% | 29.3% | ||
| Q3 25 | 1.4% | 40.4% | ||
| Q2 25 | -19.5% | 43.0% | ||
| Q1 25 | 82.5% | 44.1% | ||
| Q4 24 | -76.2% | 25.8% | ||
| Q3 24 | -27.7% | 38.4% | ||
| Q2 24 | -21.5% | 37.0% | ||
| Q1 24 | -21.6% | 32.2% |
净利率PTCTRBCAA
| Q4 25 | -82.0% | 24.2% | ||
| Q3 25 | 7.5% | 31.8% | ||
| Q2 25 | -36.3% | 33.5% | ||
| Q1 25 | 73.7% | 34.8% | ||
| Q4 24 | -30.9% | 21.2% | ||
| Q3 24 | -54.2% | 30.1% | ||
| Q2 24 | -53.1% | 29.0% | ||
| Q1 24 | -43.6% | 25.4% |
每股收益（稀释后）PTCTRBCAA
| Q4 25 | $-1.63 | — | ||
| Q3 25 | $0.20 | — | ||
| Q2 25 | $-0.83 | — | ||
| Q1 25 | $10.04 | — | ||
| Q4 24 | $-0.85 | — | ||
| Q3 24 | $-1.39 | — | ||
| Q2 24 | $-1.29 | — | ||
| Q1 24 | $-1.20 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9B | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-205.3M | $1.1B |
| 总资产 | $2.9B | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PTCTRBCAA
| Q4 25 | $1.9B | $220.0M | ||
| Q3 25 | $1.7B | $484.2M | ||
| Q2 25 | $2.0B | $484.8M | ||
| Q1 25 | $2.0B | $793.0M | ||
| Q4 24 | $1.1B | $432.2M | ||
| Q3 24 | $1.0B | $530.9M | ||
| Q2 24 | $1.1B | $400.1M | ||
| Q1 24 | $884.8M | $546.4M |
股东权益PTCTRBCAA
| Q4 25 | $-205.3M | $1.1B | ||
| Q3 25 | $-155.8M | $1.1B | ||
| Q2 25 | $-206.5M | $1.1B | ||
| Q1 25 | $-185.8M | $1.0B | ||
| Q4 24 | $-1.1B | $992.0M | ||
| Q3 24 | $-1.1B | $979.7M | ||
| Q2 24 | $-980.2M | $955.4M | ||
| Q1 24 | $-893.9M | $935.6M |
总资产PTCTRBCAA
| Q4 25 | $2.9B | $7.0B | ||
| Q3 25 | $2.6B | $7.0B | ||
| Q2 25 | $2.6B | $7.0B | ||
| Q1 25 | $2.7B | $7.1B | ||
| Q4 24 | $1.7B | $6.8B | ||
| Q3 24 | $1.8B | $6.7B | ||
| Q2 24 | $1.9B | $6.6B | ||
| Q1 24 | $1.8B | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-34.3M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $-36.6M | $161.1M |
| 自由现金流率自由现金流/营收 | -22.3% | 170.9% |
| 资本支出强度资本支出/营收 | 1.4% | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | $702.3M | $288.6M |
8季度趋势，按日历期对齐
经营现金流PTCTRBCAA
| Q4 25 | $-34.3M | $168.2M | ||
| Q3 25 | $-66.3M | $33.3M | ||
| Q2 25 | $-58.3M | $8.4M | ||
| Q1 25 | $870.1M | $93.2M | ||
| Q4 24 | $-30.0M | $149.0M | ||
| Q3 24 | $-77.0M | $51.3M | ||
| Q2 24 | $-71.5M | $4.0M | ||
| Q1 24 | $70.8M | $71.2M |
自由现金流PTCTRBCAA
| Q4 25 | $-36.6M | $161.1M | ||
| Q3 25 | $-69.7M | $30.8M | ||
| Q2 25 | $-59.6M | $5.2M | ||
| Q1 25 | $868.4M | $91.6M | ||
| Q4 24 | $-33.8M | $143.2M | ||
| Q3 24 | $-77.5M | $49.8M | ||
| Q2 24 | $-78.8M | $2.7M | ||
| Q1 24 | $61.2M | $69.1M |
自由现金流率PTCTRBCAA
| Q4 25 | -22.3% | 170.9% | ||
| Q3 25 | -33.1% | 32.9% | ||
| Q2 25 | -33.3% | 5.5% | ||
| Q1 25 | 73.8% | 67.4% | ||
| Q4 24 | -15.8% | 160.0% | ||
| Q3 24 | -39.4% | 56.5% | ||
| Q2 24 | -42.2% | 3.1% | ||
| Q1 24 | 29.1% | 57.5% |
资本支出强度PTCTRBCAA
| Q4 25 | 1.4% | 7.5% | ||
| Q3 25 | 1.6% | 2.6% | ||
| Q2 25 | 0.7% | 3.5% | ||
| Q1 25 | 0.1% | 1.2% | ||
| Q4 24 | 1.8% | 6.5% | ||
| Q3 24 | 0.3% | 1.7% | ||
| Q2 24 | 4.0% | 1.5% | ||
| Q1 24 | 4.6% | 1.7% |
现金转化率PTCTRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | -4.17× | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | 1.00× | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
